@ [aap 2\ oon Qe wh opectwial Studies <9 & 4 Xewrs ® FoA Safety veview 0 olays O chacals shobes—-o F 05 QyW/DA Review 9 1 Years ~~ O ie otek aohudkies =P phase 4 | . phase 2 ul phase 3 MW —— “TViwme Courde eS Ae olevelopmes of ned Area AN Ge WAS) pls cH S2P oo gi) nct\\n 3 \ ae eS I (gir lercanoter Fletg old, ak Br a qavy SOS ee ae Sources of newly’ F Oo te Nel @ @ vesults of wreny Years 4 eek : neouheat vem Planks « @ by accident. ee? IP) te,o00 Kraul plascts- BiAudd: chegrad:s ; ; @ Senisuthekic obrug. ee —_» a i Meo de: Rell x biolegic drags oo reecional ac ibaies .O theryendis Pens a \meune therapies @ Vvaeenes- CS oS ee KSewrceS of estvarehs» urine of pregnank anes. * KSymclnctic chextGls— ovel cahucepives > >2) xLissne Culhwes go « JmumpssinPluen2a Vo ceive s \ wey ae Plaids of eli ek wevuroella (aermean viens les) vs emibige. oAuck enbyjo * \ Smal\BX Vaccines go OT eae Vom, 78 JA oe ee amp H poliomyelitis VacomeSab Venak monkey fPssue ¥ Smallpox Vacdines@B skin of \oovine Calves + —? 4 Se I oe - plier abillty B cells to produ Hig p Oe cae protets. Sarees Stet D insWly > De od-in alfa err ee | @ Kleferen Deakins RB vactlne beat shy \982, hs es erie oe ce bhn\ 2 LU\ de ene see Wore ea o aa ee ee Ss Cx 5 rnalenk aotel production se hu oT \in bo SS parr sgh (GE _/° ability cell te prtace antibody aye Os Cage e & Se Wher gals « Div gt ee el mAb @ was [rwnaab) aah 51M Co, rele ods slasd ale Sober x trons lads Vejectiondlrus th ldo >AQ : ; @' Wann gene Nrermpse — lel, orf eg dee as Ear dex bp LBP By oe Kai we +dys yes we Leo 600 \ Sree JP o ee JeneS \y \wmans BY? Siew © oli se Su ms eee ae x 2 Ave) For SM Semon a cltminshrablens % ow side Vee booly Cex .- ie % Cotta the ‘booly Gavive } ih by gene thermpy product Ove direslly tothe pm ied | aaa mee oro * - an HF yajer owe errr ae BS eb Wah OMG fee dd oun eget or ge de ficiercl [5 ad ook pod a aK Lost ed, Ud oy 7 i Ree (Ged DRVO) iar ec owes @ desired ekheck /@ wwimah obesye oak fosivg Freund - @ ghesivesk rok e D oprwok onc onch ducedten. @ no side eheck © el\ivrmakest Grant ‘pedi eShictody , @Eocwr ah. ConQraely) , ancl Ca Mrdk Vestdurd efeds @ plermace Tad eek -/@ phystady amd chentalty Sub ee ee Cowkmatoriad chentshry 2° 222 Ce5Galerap et ete) ae EISELE 15,000 P nnaGQ) MolecukormediVatiente = ys hh agit 7 P —~_# BO sefulne sg) 51S cc bel hay Oo ; <= :, © enhanc ty speafichy =p bedy Bae’ Site« @P petecty - @ imprevivg rate ant expecta of abserpion @ edifying Hime Course th the body @ Reslucty faxiciy . © chaygiy prpsro or chemi ad poreeties ¢ solubility) fo provide olesWeorl feshured« | News 9 2? SL oP \ AL gPes\ Bo ioP SAR eat Vr des seeds & i" ePobe aig he ee eb allbs | Ney wey nev) chert el entities. [iyi =p preclsce P a Ww prevel therapaic ageks: Ollockby ,@ biSragtton UW dae as prader @ reversal of clientes process t enalapril i, es Ft ieee Te Seis pe lecubor grnph'cs 50 (ahuelus toda p12 sao Saas atles) ately int, slo dle CID, les va, SSD —p> A LE AD Compoury! geo prototype Chem) caf has O oleSired bidelegsod — 3 or @ harm aC ele iC: activity « ae) de Dull shiek oo ie a OW be Coty who bs des ale Git) Soe dle) Gabe up O15 So27) Ub det lA Gepholospring i 65,2) predrigd? — Convertton from inactive te active. we LSA 2303 FY BDV, WDA BR doe SS yaleprt =p enala vi et @® 4 19 enaiep e : oe ahs aa prodrg ) i cue} OQ Solubiltl] ,@ absorption - P hin giability, Oprbte relate « 2 tuzs EPs js et . a _—S— > ee ye Solubl itty =P poe itvew sEo core cen Sevlo\ aeite (5 ecb iam smeccinae) joo Bes s peo! ality , 1? gun ebux (de Covele: € ) ge Vv {haloperidol Bold POSS Se —— wT, ad Ne 8rd, io peat # Bie SHeb ility a o eng mar or®@ oe ac prodli4) get © ob Va lacyc\oviv=g pre drug of acyelovin © Lica oe ee pan © 55% bicaveilability- oR A be = Lt @ Kacytleviv = To~ 20 % bioavarlabilitys cd oer or ex velarse i Levedipa—p cress BBB - ig at Vode of nefabolie ¥ dlopomive =P unable Cro BRR pe SS ak : ae a Set al ConVersrorty Ae'lo \'o\ wv a nite 4 Sv eeu ovat Gort eelals DA ae es! wos fod & Rib ph hee) ae LAM eV S's a peg hi sf Be Eu * | ) +, | QO abserpek 1 AbStri bute @ Stored , OvrefabeliZe @ exclted. O a Peot action oof badbefi CMS 1 H3suety organs: 4 Cel anol tBsue culture ge to foxicily a ar polls iat. cola de ee Comper ymaclek ge ja alia OSs ore RD ee a poe eb, (piechwal sale) bv =P elie, elem BI, Ege AY wadaiar, Lee ae = eel ee Cae «pharma cology & chentlf opreperties /@ hochemrgl ond Postale gue $01 | @ mechanism ef acHon-+ : @ albosorptton 3 olispribubiony biotron formab ton exerefion « ——~2 £ pimearertc? a sh lotta: 4 pharmacekinckic = cpudy fore sophisti eiswial pharma gy? Whe? g ike active cetes ef entpres arese ibd . @ phesrhate of BLS G1 Recerters \i (0) Carbexs) ,@ anne , @ s (0) tonre, OCovaled aiD 53lo| AZ) S LAD Nolen Adz eos (seturetesl) see pokuhier ms Sa SN late. a es BUR i ee eis BH, pe We Dru ge i ee | Se Mentoceerete ee ar (Carrere. sc ea DO Ae 2 shé Mu 2) ola aus orvakf Ge celia» (brobvenstere BIT aed le dF BE) Wye Z ASS, UG AN ey perso BEE ce eet lnltiere » re @ olebominar ton wh Khar mechemism aba chien eS a Le ee ip Re diekine a prarmacdhTe P previle ge wr urtre & © iwvitr eA Gane sch eb e cheters ie enti heck 99 @ invive aries? els 5 poriatale fe © whole potas ae Pe Ph vjene ed specie ° @ animal S predels ol Wumer olisense* Ss a eau a 7 ae ae Ove Soak a eel se ak e Ved GOL Nae \ We es SUL - i os (Gat vines Ve Us Yaya cot, © ovinlabitis me pare ap WUE Les coe shabiton b& expernce with a ee dks A bess Oinlalion festirg In these species: @iv= Jacpaj relat |e erie By ei cen, e =) ele) bear ep, Vode We Jazrs eV 5) ack, Belo OA es span lt COVA SE RS bn Ca) 32 hn be) pos eee ave sbhdre Betecom * a tt wen V1 clexe bE 6% DG ato of v 1G td Variniios - 399 jas ele andasiloke « -absebtg 1% do othe Cr ROLY 65 ENS Bs Conimals md SE aie Kw “wae hea Ba Bins yar’, S CZ 2 Se Bind A worry O effect @® cfiet fos Cox city ~% Des =e/O aie Oresp infers ef eu Se feet ats as ee aspire ee ¥Ra b bits > L oat: Congation mice CMS 7 RD PMP CHS i pike ed Mele iee ee pry mefabel’3 =P (ADEM A aA 2 Sy Sarna ‘ ole one rede cee bl ere Polrs au, —,? ee Oe eee, 08 FY PS che gubptance’s fokiety with Shot tem C acudt). @ ~The subptanced eA WINS leptom Caleta @ Spe cFie © vega 4 exierty- e The malt, sity ee of fexicily - Q fe se response 0 OP igs for lex Jrigh 1 ind evrreslete ipges over seectfiedkbime fo Goders ve produc % ,fdaten. @ Cardnegente ord ponoboyce 5 DenaCligee ;) De pete or short-term Toxicity e- Grae). = me yraltip le of” Single olase = Bee ee wy» (2 Ad aD, matey ap « = ie £ abeas. ary \se Nek \oe \eoo 3 Yb ak" = ea (oo eee Pb aiks Ep a liz ory \ Seo Sty Dorvest iD ee gression a yeuers Se ee perder 12 DOOD aloo cox tt, ee PES an De BL ANS aoe ever tonterty) sur ar Ulex es aahiake te texte] awe) ae BND (SIG Yy Ga Se OF ele eer arses Ob Aig cook Aoki habitS- @ wt chagt /@ Texte eMesk, @ phiverctr deo @ fry other IV° 0 uke ee veins fem | so bays pot close periedt- | ee a : alee hen Zo se Ms VI Hobs ex — oe ee a Aare Sie le) Siem Dum \r\m we ye’ os are. w2ASD Woh Gly arti © inertial seit © de Ket idinnal2 go ee oCUN ays @ Guo cde ov Suda croc Saabs ge? 2 vik alls Shot ek tK3 : See ee to WA Sua 4 el LN Gigli ht JF 8 MA 2Aso%y ca aps chi tee lym (6 Bro Clow aderncslche high) ele? fie ge Whe °i eee aolvers Yom if ; Ose al. WME Bap GR ANN 49) Uh PLES ATH 4 2 Gib) Sd dls tot ter oO OY LMS EBs las Wl ab LUlox yp HR eproduckietton studies Bo SOW 3TB fd malian reprdachion) dee OLE) elite Clee aol py) bay" on mydg Bayo Ny ahead PONS 2 aly 3 (Eabyponic 7 pests\ oP Sle del le 2ge —> Fr exbyyjo deoxraty Yabbit) ——y es SeloID) xe oxic’ oD) - enct nN ot prdegenicry shu ates Se aS ole Salmon Ne - ral ‘s < ds Var ok Ge o> Ne, o(mtedtton Ogee wheter Ed PAS ee ae ——t few onli’ ; assahndtion vate, % pre Gorm © sebilty © partition coctficiedd, Oo! @ physical per @ Spabality ¢ Ag eds oli ae po ee ee ay) ONE er ¥.O Solubility 3° (aq neers gdvvilty) Qas AZ vor systerse aloser prich t= Vey 2 es on €) oats abl ette A 2 oren’ dere me of aie nae ave oun 3° sta ee ; p7e Cor?’ 3 OSs @ rec HOO* pogo Nee ee Gee a D oles oe crekbicionk ge 3 C Lipophibie byare philic) Di) 2 pvt ar delet LES ON €R8 iw Nw ad WS ne Pes AAG 2S PIP ND 36 pe rare eee 3 Sy, ae 5 puns DRE SES BRR OS s, Beppe ibs spud ID gebstance disselive nw meg inme oP Q wcih @ pase ,O Salts or Cbd te dae Ck G prt VZe « @ prysial forme\9\ OD phystat form ee a a Byera a Com ween ae 7 @Q Cryst Keele ®amorpheus teow pe De pian) ae eS sags ay | boa gurbate ot yp BLE WEI x pane Fare Oly, La dum wre, ee ee ee ee © shabriity eo — BRAS swe AUN, AB Meo, alm phystod stability ra chem GI Shalit Gockiont ola) LE Coxtolatie oleGrptiag ao 2 w Vole m -2)3\ aby 314 a ab We as, 05,03 BabA Lon aay aes x GDN up ga rads wis Bole, Te ard ¢ (drug $rbiltty testJ) SYREN ets Pie 87a sent] /[ad/ed \ S22 Beer east J be AE ALE 9G oor @ packaging ss ~ AF Sia ott ods ey ee 7 Clmgl shullieS Bo V2 (ne Moke, aacl Bla Wa Phe og phased => Bie wb pds «22 omy 5 oa ee phase 2 =p Poth a eho Lh Excipiedrarses, Dobe xe ADMe- A _Brabu hae on ~-o 4 \40 Jobe phase 3? QOBL ed 2) AID)? (Fob Gormerke3 eau th Shey colin) Sib Hes SMe bee Faby ce BB ODS ON Gs bon Bs adel ede, A HPP oy. ‘ te lye LB43) ear) 43) Seub > aA ce Db be SK phy Aer Bs D\ ep dion a © cat ellie (barbiturate) lex O hens eleseP S © Lager dsc? yponate ee gure Ve reo) Sx Pas apo) dap Sai 0 & ZN JQ oe acoso OW —_P Space DOE Cp Ae eye Aabsraee a> Pie bd NAN oe iS SH # [omy wet cu & Dp BUCPreR Bd ceanalties Ezy fo (4%) Cowdliat ov agar o Vues CS oD coe te so Se Gl «cea? Ab, hv Ys AIG y ode gears Oe Ae ek toe" Tp RH HK PSs Le» 7 Qn? “ag idetincs eb HL Deu aleve oltecks oak ool A (poerwcegertior) St endo oly morphism a peyraphi) . onl apbsiger CGE , ee garb “OL aw ¥Body ely oA $° See) Cy Bae S2H\ de ale st (qelghinets\ Ca— \o\ dS 2 ( dng) bIAAA else? awh ae F dds See (Sein) ded Is Grp Ky) (Sto 2 eet ce Os V2 x14) Beely surhace ciara Arg/nd (cbt Bonar (ronegre) een Mr VEX Vi, ibs BSA 23s dete oP BAe spa [(verevt ki BSA a ae ov Bz / Ra At ee 2 Dee PD P\ S02, SUN G3 € oud (G4 _ DOL? harrnd thermperdre swoon ne Ph eee et pL Yorl eliy cb ee sole 4 oa oo Ot ee” % pakhelegiz Ghualies b IS EB cto i» 25 GS WN “yp 23 an KS gegBv7 AA aeAN abl PS) oS sts \s (lowe level ort b+ aw ne ecg ere ay Sa Le ee aa ia fe {histamine hintels sa 3 Tolerance 4 Dae ie Seng MOU bo God Sy be) we)eor ae) hh Epld aU os eee? ; = & t SAsien cha) 35 OW WV vapid B— ef clea aa dD,» vbr SVL ALE sis : «sb BO Gy da SN eh patel) vera, (orbiy)sle stnun Ble V1 Saal Myo x swrP 54> ebb GOA Ww Abbe 5 ee ee ee ¥ La beliy =? eee eDGh soe 2 4 Opackyig @iusert packsiy or packs) Inset @ Company (Mereture => ag ay @ Advertising, acd promettonal m or | Seb p ASN PALLabeling (6 sere 3 us 1S © pecrighten of LAA SD Corkind® 20> @ cliwad praren Cle QB) Warns Dp recastions , © holes venation &) Drv abuse polepalenCe / @ oeverdeseAty gi aes, Betis @ VDesege aval aolniistyrtton (DP Ho? eupplical: PEE HL AY BS FOR —— ee ae ND VEL bP WML da ee Hees dest od ee @ cage \n Cormubedion pls @ Ue of a or ferod Fa eiNtty Oe Cokractert2 wt = £ Expire on date tension = yeh O20 \oe abelly Charge A BO Any Lebel CORIE —crygits aap shoe Y 4s) Le ad Me path Edel aly bo a Yue eae ee oh PV Ms Od ie : Cplad) +